These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 8485565

  • 1. The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE.
    Wallace DJ, Linker-Israeli M, Metzger AL, Stecher VJ.
    Lupus; 1993 Feb; 2 Suppl 1():S13-5. PubMed ID: 8485565
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus.
    Jung H, Bobba R, Su J, Shariati-Sarabi Z, Gladman DD, Urowitz M, Lou W, Fortin PR.
    Arthritis Rheum; 2010 Mar; 62(3):863-8. PubMed ID: 20131232
    [Abstract] [Full Text] [Related]

  • 9. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.
    Parke A, West B.
    J Rheumatol; 1996 Oct; 23(10):1715-8. PubMed ID: 8895146
    [Abstract] [Full Text] [Related]

  • 10. Antimalarial drugs, systemic lupus erythematosus and pregnancy.
    Parke AL.
    J Rheumatol; 1988 Apr; 15(4):607-10. PubMed ID: 3397970
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN.
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
    McLaurin EY, Holliday SL, Williams P, Brey RL.
    Neurology; 2005 Jan 25; 64(2):297-303. PubMed ID: 15668428
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus.
    Toubi E, Kessel A, Rosner I, Rozenbaum M, Paran D, Shoenfeld Y.
    Scand J Immunol; 2006 Apr 25; 63(4):299-303. PubMed ID: 16623930
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics.
    Omdal R, Mellgren SI, Koldingsnes W, Jacobsen EA, Husby G.
    J Rheumatol; 2002 Mar 25; 29(3):482-6. PubMed ID: 11908560
    [Abstract] [Full Text] [Related]

  • 20. The efficacy of antimalarials in systemic lupus erythematosus.
    Nayak V, Esdaile JM.
    Lupus; 1996 Jun 25; 5 Suppl 1():S23-7. PubMed ID: 8803906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.